Compass Pathways Plc (CMPS) - News Archive

In December 2025, Compass Pathways plc (Nasdaq: CMPS), a biotechnology firm focused on mental health solutions, has scheduled participation in two notable investor conferences aimed at enhancing its visibility and attra...

Navigating New Frontiers: Dr. Jeffrey Jonas Joins Compass Pathways in a Strategic Board Appointment Amidst Financial Trials In an era where mental health is increasingly taking the centre stage in global discourse, biot...

In a significant advancement for mental health treatment, Compass Pathways plc (Nasdaq: CMPS), a leading biotechnology company, has announced the publication of groundbreaking results from its open-label Phase 2 clinica...

Compass Pathways plc, a biotechnology company traded on Nasdaq under the symbol CMPS, has been forefront in the burgeoning field of mental health innovation. The company s recent pricing of an underwritten offering of o...

LONDON - In a significant development for the biotechnology sector, Compass Pathways plc (Nasdaq: CMPS) has announced that it will be added to the NASDAQ Biotechnology Index (NBI). The addition will go into effect prior...

In the ever-evolving landscape of biotechnology, companies like Compass Pathways plc are at the forefront of transforming mental health treatment through innovative therapies. Based in London and New York, Compass Pathw...

as Challenging: Compass Pathways Strives to Innovate Mental Health Care Amid Financial StrugglesIn a recent press release, London-based biotechnology company Compass Pathways plc has announced the appointment of Lori En...

In a recent open-label phase 2 study, Compass Pathways plc announced positive top-line results regarding the safety and efficacy of investigational COMP360 psilocybin treatment in patients suffering from post-traumatic...

London, May 02, 2024 - Compass Pathways plc (Nasdaq: CMPS), a renowned biotechnology company committed to advancing patient access to evidence-based mental health solutions, has joined forces with Mindful Health Solutio...

The key leaders in the realm of psychedelic-assisted psychotherapy, Compass Pathways Plc and Journey Clinical, have announced their unique research collaboration as they seek to pioneer an innovative healthcare delivery...

Article for :Compass Pathways Undergoes Leadership Changes as Shares Fall and Losses MountCompass Pathways, the pioneering mental health care company focused on developing innovative therapies for treatment-resistant de...

Compass Pathways and Hackensack Meridian Health Collaborate to Optimize Clinical Model for COMP360 Psilocybin TreatmentIn recent years, there has been a growing interest in the potential therapeutic benefits of psychede...

In a paradigm-shifting development for the global mental health therapeutics sector, Compass Pathways Plc (Compass), a British mental health company dealing in research and development of therapeutics has entered into a...

Compass Pathways Plc, the healthcare innovator renowned for its investigation into the potential benefits of psychedelic substances for mental health, has shared promising updates on its phase 2 study with COMP360 psilo...

In a groundbreaking development within the field of mental health, the results of a recent study on psilocybin treatment for bipolar II depression have been published in JAMA Psychiatry. This pioneering research signifi...